Gebruikersprofielen voor "Kremer, J. "
Jan KremerProfesson in patientcentered innovation Geverifieerd e-mailadres voor radboudumc.nl Geciteerd door 15589 |
[PDF][PDF] 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the …
The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
Women's emotional adjustment to IVF: a systematic review of 25 years of research
CM Verhaak, JMJ Smeenk, AWM Evers… - Human reproduction …, 2007 - academic.oup.com
This review provides an overview of how women adjust emotionally to the various phases of
IVF treatment in terms of anxiety, depression or general distress before, during and after …
IVF treatment in terms of anxiety, depression or general distress before, during and after …
Physical exercise and psychological well being: a critical review.
D Scully, J Kremer, MM Meade, R Graham… - British journal of sports …, 1998 - bjsm.bmj.com
The relation between physical exercise and psychological health has increasingly come
under the spotlight over recent years. While the message emanating from physiological …
under the spotlight over recent years. While the message emanating from physiological …
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: results of a twenty‐four …
S Cohen, E Hurd, J Cush, M Schiff… - Arthritis & …, 2002 - Wiley Online Library
Objective To evaluate the efficacy and safety of anakinra in combination with methotrexate (MTX)
in patients with active rheumatoid arthritis (RA). Methods Patients with moderate‐to‐…
in patients with active rheumatoid arthritis (RA). Methods Patients with moderate‐to‐…
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results …
P Emery, E Keystone, HP Tony, A Cantagrel… - Annals of the …, 2008 - ard.bmj.com
Objectives: The phase III RADIATE study examined the efficacy and safety of tocilizumab, an
anti-IL-6 receptor monoclonal antibody in patients with rheumatoid arthritis (RA) refractory …
anti-IL-6 receptor monoclonal antibody in patients with rheumatoid arthritis (RA) refractory …
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve‐month results of a phase IIb, double‐blind, randomized, placebo …
JM Kremer, M Dougados, P Emery… - … : Official Journal of …, 2005 - Wiley Online Library
Objective To determine the clinical efficacy, safety, and immunogenicity of abatacept (CTLA‐4Ig),
a selective costimulation modulator, in patients with rheumatoid arthritis (RA) that has …
a selective costimulation modulator, in patients with rheumatoid arthritis (RA) that has …
2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis
L Fraenkel, JM Bathon, BR England… - Arthritis & …, 2021 - Wiley Online Library
Objective To develop updated guidelines for the pharmacologic management of rheumatoid
arthritis. Methods We developed clinically relevant population, intervention, comparator, …
arthritis. Methods We developed clinically relevant population, intervention, comparator, …
Once‐weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double‐blind, placebo‐controlled trial
EC Keystone, MH Schiff, JM Kremer… - … : Official Journal of …, 2004 - Wiley Online Library
Objective To evaluate the safety, efficacy, and pharmacokinetics of 50 mg etanercept
administered subcutaneously once weekly in adult patients with active rheumatoid arthritis (RA). …
administered subcutaneously once weekly in adult patients with active rheumatoid arthritis (RA). …
Computer visualization of three-dimensional image data using IMOD
JR Kremer, DN Mastronarde, JR McIntosh - Journal of structural biology, 1996 - Elsevier
We have developed a computer software package, IMOD, as a tool for analyzing and viewing
three-dimensional biological image data. IMOD is useful for studying and modeling data …
three-dimensional biological image data. IMOD is useful for studying and modeling data …
[HTML][HTML] Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition
MC Genovese, JC Becker, M Schiff… - … England Journal of …, 2005 - Mass Medical Soc
Background A substantial number of patients with rheumatoid arthritis have an inadequate
or unsustained response to tumor necrosis factor α (TNF-α) inhibitors. We conducted a …
or unsustained response to tumor necrosis factor α (TNF-α) inhibitors. We conducted a …